Noticeably, treatment of AR− prostate cancer cells with ATRA did not change the expressions of HOXB13, EZH2 and DNMT3b at mRNA level (Fig. S5B), implicating a different mechanism of ATRA action in this particular cell background. The gene discussed is EZH2; the disease is prostate carcinoma.